logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

North China Pharmaceutical Co., Ltd. has obtained the drug registration certificate.

date
22/05/2026
North China Pharmaceutical announced that the company recently received the "Drug Registration Certificate" for Rosarsatan capsules issued by the National Medical Products Administration.
Latest
3 m ago
Haruhiko Kuroda, Governor of the Bank of Japan: We have taken into consideration the Middle East conflict and discussed its impact on the economy, prices, and market trends.
3 m ago
UBS: Global non-energy shipping has clearly rebounded.
4 m ago
Bank of Japan Governor Kuroda Haruhiko: When asked if the Prime Minister agrees with the Bank of Japan's monetary policy stance, he expressed that we have been able to engage in positive dialogue on multiple levels.
4 m ago
Bank of Japan Governor Kuroda Haruhiko: Minister Sanae Takaichi outlined the government's measures to control prices.
4 m ago
Link REIT (02598.HK) spent HK$1.7325 million on May 22 to repurchase 319,000 shares.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.